Ally Bridge Group (ny) LLC: 13F holdings, Q2 2026
Hedge fund · SEC EDGAR filings (CIK 1822947) · Explore on the interactive board
Ally Bridge Group (ny) LLC disclosed 23 US equity positions worth $77.6m in its Q2 2026 13F filing (holdings as of June 30, 2026, filed August 14, 2026). Its largest position is NERV at 15.6% of the reported book, followed by PROMIS NEUROSCIENCES INC, TRAX. The top ten holdings are 64.8% of the book, and the portfolio behaves like about 15 equal-weight positions. Versus the prior filing it opened 10 new positions, added to 2, reduced 9 and exited 7. Note: this manager's most recent filing is 3934 quarters behind the newest quarter on file, so these figures are history rather than current positioning.
What does Ally Bridge Group (ny) LLC own? Top holdings as of June 30, 2026
Change is measured in shares against the previous filing (Q1 2026), so price moves do not read as decisions. This quarter: 10 new, 2 added, 9 reduced, 7 exited.
| # | Stock | Sector | Weight | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|---|
| 1 | NERV MINERVA NEUROSCIENCES INC | 15.6% | $12.1m | 2,175,802 | 31% | added | |
| 2 | PROMIS NEUROSCIENCES INC | 10.5% | $8.2m | 620,319 | 50% | added | |
| 3 | TRAX FIRST TRACKS BIOTHERAPEUTICS | 7.4% | $5.7m | 284,287 | – | new | |
| 4 | AXSM AXSOME THERAPEUTICS INC | Healthcare | 5.2% | $4.0m | 16,493 | – | new |
| 5 | ASMB ASSEMBLY BIOSCIENCES INC | Healthcare | 5.0% | $3.8m | 140,000 | – | new |
| 6 | WHWK WHITEHAWK THERAPEUTICS INC | Healthcare | 4.8% | $3.7m | 817,939 | 0% | held |
| 7 | EWTX EDGEWISE THERAPEUTICS INC | Healthcare | 4.4% | $3.4m | 83,300 | -48% | reduced |
| 8 | CLYM CLIMB BIO INC | Healthcare | 4.2% | $3.2m | 249,172 | – | new |
| 9 | KURA KURA ONCOLOGY INC | Healthcare | 4.1% | $3.2m | 290,000 | – | new |
| 10 | CTMX CYTOMX THERAPEUTICS INC. | Healthcare | 3.7% | $2.9m | 775,000 | -14% | reduced |
| 11 | AVTX AVALO THERAPEUTICS INC | Healthcare | 3.6% | $2.8m | 150,000 | – | new |
| 12 | PALI PALISADE BIO INC | Healthcare | 3.3% | $2.6m | 1,229,000 | – | new |
| 13 | SLDB SOLID BIOSCIENCES INC | Healthcare | 3.3% | $2.6m | 255,959 | -67% | reduced |
| 14 | ANTX AN2 THERAPEUTICS INC | 3.3% | $2.5m | 526,315 | 0% | held | |
| 15 | URGN UROGEN PHARMA LTD | Healthcare | 3.3% | $2.5m | 69,183 | -66% | reduced |
| 16 | CATX PERSPECTIVE THERAPEUTICS INC | 3.3% | $2.5m | 743,958 | -20% | reduced | |
| 17 | IDYA IDEAYA BIOSCIENCES INC | Healthcare | 3.2% | $2.5m | 67,500 | – | new |
| 18 | IVA INVENTIVA SA | 3.1% | $2.4m | 634,800 | -15% | reduced | |
| 19 | ALMS ALUMIS INC | Healthcare | 2.8% | $2.2m | 76,459 | -54% | reduced |
| 20 | OVID OVID THERAPEUTICS INC | Healthcare | 2.2% | $1.7m | 624,561 | -78% | reduced |
| 21 | EPRX EUPRAXIA PHARMACEUTICALS INC | 2.1% | $1.7m | 252,175 | -62% | reduced | |
| 22 | IBIO IBIO INC | 0.9% | $682.8k | 390,147 | – | new | |
| 23 | TRAW TRAWS PHARMA INC | 0.9% | $663.0k | 786,236 | – | new |
What did Ally Bridge Group (ny) LLC sell? Positions exited since the previous filing
| Stock | Prior weight | Prior value |
|---|---|---|
| PRAX PRAXIS PRECISION MEDICINES I | 29.5% | $10.6m |
| SLNOEUR SOLENO THERAPEUTICS INC | 18.7% | $6.7m |
| CMPS COMPASS PATHWAYS PLC | 16.1% | $5.8m |
| TARS TARSUS PHARMACEUTICALS INC | 15.8% | $5.7m |
| CAPR CAPRICOR THERAPEUTICS INC | 9.7% | $3.5m |
| IKT INHIBIKASE THERAPEUTICS INC | 6.2% | $2.2m |
| RLMD RELMADA THERAPEUTICS INC | 4.1% | $1.5m |
Sector mix
| Sector | Weight |
|---|---|
| Healthcare | 53.0% |
Sectors cover positions whose ticker resolved to a sector; the remainder is unclassified, not cash.
Filing history
How concentrated is Ally Bridge Group (ny) LLC's portfolio?
Across every quarter Ally Bridge Group (ny) LLC has filed, its median largest position is 13.0% of the book and its median top-ten weight is 65.0%, which WhaleCreep classifies as concentrated (the gate is a median largest position of 5%). Of 8.0 completed holding spells, the median lasted 1.0 quarters; 23.0 positions are still open and their final length is unknown.